Nabriva Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, Ireland and KING OF PRUSSIA, Pa. and SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat …
 
       
       
  
 
     
     
     
     
     
     
     
     
     
     
     
    